About this trial
Intermittent hemodialysis/diafiltration is a current renal replacement therapy (RRT) institued for ICU patients with AKI. For a better clinical tolerance, iinternational guidelines advise to use cold dialysate, increase duration session, decrease blood and dialysate flows, and increase level of sodium dialysate concentration (≥ 145mmol/l). Indeed, the use of a Na concentration dialysate \> 145 mmol/l improves intradialytic hemodynamic tolerance but it may also induce fluid overload by the transfert of sodium from the dialysate compartment to the blood. Yet, fluid overload has been strongly associated with mortality in critically ills. The investigators hypothesized that the use of a level in sodium dialysate at 140 mmol/l with slow low efficiency daily dialysis-filtration (SLEDD-f) will permit a fair intradialytic hemodynamic tolerance without the adverse effect of intradiaclytic Na loading from the dialysate. Two randomized groups of ICU AKI patients treated by SLEDD-f will be compared in terms of intradialytic hemodynamic tolerance and overload accordong to 140 or 145 mmol/l of Na in the dialysate
Eligibility criteria
Qualifiers
Age > 18 years old
Acute kidney injury requiring renal replacement therapy
Dialysis type: on line sustained low efficiency dialy dialysis -filtration
SOFA score > 5
Disqualifiers
Chronic kidney disease stade IV ou V
Obstrutive acute kidney injury
Renal tansplantation in the year before ICU admission
Moribund with risk of death in the 48 hours
Trial design
Treatments tested in this trial
- Lowering sodium concentration dialysate
- Highing sodium concentration dialysate